DSP Vigilance Group’s mission is to enable the development of safe and efficacious solutions for unmet medical needs, using data representative of the real-world populations they will serve. DSPVG positions itself as a bridge, connecting patients, sponsors, and clinical investigators, with a focus on dismantling clinical research participation barriers for underrepresented patient populations. As a network of independent community-based clinical research sites, our hybrid model combines on-site visits with remote elements (ePRO, home nurse visits) and mobile clinics to take trials to meet participants where they are. While maintaining all therapeutic areas. With a specialized focus on the psychiatry and vaccine niches, we equally implement regulatory compliance and quality assurance in managing several other therapeutic area clinical trials.

VISION:

To enable global access to safe and efficacious innovative treatments that improve lives by empowering healthcare providers and connecting diverse patient communities. We are dedicated to accelerating medical breakthroughs by providing unparalleled services that champion inclusivity, adapt to evolving challenges, and deliver impactful solutions for our sponsors and partners.

VALUES:

Scientific Integrity: Upholding the highest ethical standards and rigorous methodologies in all research endeavours.

Patient-Centricity: Prioritizing the safety, well-being, and dignity of every clinical trial participant, fostering an inclusive environment where diversity is valued and celebrated.

Collaboration: Building strong, collaborative relationships with healthcare providers, sponsors, and patients to achieve shared goals.

Innovation: Embracing cutting-edge technologies and approaches to drive medical advancements.

Adaptability: Remaining agile and responsive to the ever-changing landscape of clinical research, finding creative solutions to overcome challenges and meet the evolving needs of our partners.

Results-Oriented: Delivering efficient, high-quality research outcomes that exceed expectations, accelerate the development of new therapies, and help sponsors meet their regulatory requirements, including patient diversity goals.